Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.
Alexander E DrilonDaniel Shao-Weng TanUlrik N LassenSerge LeyvrazYongmei LiuJyoti D PatelLee S RosenBenjamin SolomonRicarda NorenbergLaura DimaNicoletta BregaLin ShenVictor MorenoShivaani KummarJessica J LinPublished in: JCO precision oncology (2022)
fusions in patients with lung cancer.